ManageAnticoag APK

24+ votes, 4.50/5

ManageAnticoag helps clinicians navigate the risks for anticoagulated patients... [readmore]


⇣ Download APK (15.31 MB)

This is an original APK file direct fetch from google play. It is safe to download and free of any virus.

Version 4.0
Update
Size 15.31 MB
Category Medical
Developer American College of Cardiology Foundation
Downloads ↓ 11.3K
⇣ Download APK (15.31 MB)

This is an original APK file direct fetch from google play. It is safe to download and free of any virus.

File Infos

License type Free
Version 4.0
Size 15.31 MB (16054055)
Filename org.acc.BridgeAnticoag_42_16054055.apk
Requirement 5.1 and up
Type app
Category Medical
Package name: org.acc.BridgeAnticoag
Slogan: ManageAnticoag helps clinicians navigate the risks for anticoagulated patients

APK Permissions


‣ android.permission.INTERNET
‣ android.permission.ACCESS_NETWORK_STATE
‣ android.permission.WAKE_LOCK
‣ com.google.android.finsky.permission.BIND_GET_INSTALL_REFERRER_SERVICE
‣ org.acc.BridgeAnticoag.DYNAMIC_RECEIVER_NOT_EXPORTED_PERMISSION


APK used Features


‣ android.hardware.touchscreen

Screenshots (24 images)

ManageAnticoag screenshot 1 ManageAnticoag screenshot 2 ManageAnticoag screenshot 3 ManageAnticoag screenshot 4 ManageAnticoag screenshot 5 ManageAnticoag screenshot 6 ManageAnticoag screenshot 7 ManageAnticoag screenshot 8 ManageAnticoag screenshot 9 ManageAnticoag screenshot 10 ManageAnticoag screenshot 11 ManageAnticoag screenshot 12 ManageAnticoag screenshot 13 ManageAnticoag screenshot 14 ManageAnticoag screenshot 15 ManageAnticoag screenshot 16 ManageAnticoag screenshot 17 ManageAnticoag screenshot 18 ManageAnticoag screenshot 19 ManageAnticoag screenshot 20 ManageAnticoag screenshot 21 ManageAnticoag screenshot 22 ManageAnticoag screenshot 23 ManageAnticoag screenshot 24

About ManageAnticoag APK

ManageAnticoag poster
ManageAnticoag APK version 4.0 poster

Latest update [menu]


Guidance for patients with acute bleeds on betrixaban has been added, along with updated reversal strategy tables in accordance with the 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants.

Description [menu]


ManageAnticoag helps clinicians navigate periprocedural planning and bleed management scenarios.

A clinician can:
o Enter patient details regarding bleed and stroke risk factors
o View individualized guidance for that patient on the advice screen
o Email a summary of the advice

The app is derived from ACC’s Expert Consensus Decision Pathways and does not replace clinical judgement. The healthcare provider is in control of all diagnoses and other clinical decisions.

How to install ManageAnticoag APK for Android [menu]


Download ManageAnticoag APK file (org.acc.BridgeAnticoag_42_16054055.apk) from SameAPK.com, then follow these steps:

Update Phone Settings

  • Go to your phone Settings page
  • Tap Security or Applications (varies with device)
  • Check the Unknown Sources box
  • Confirm with OK

Go to Downloads

  • Open Downloads on your device by going to My Files or Files
  • Tap the APK file you downloaded (org.acc.BridgeAnticoag_42_16054055.apk)
  • Tap Install when prompted, the APK file you downloaded will be installed on your device.

How to install ManageAnticoag APK on Windows 7/8/10 or MAC PC? [menu]


Download ManageAnticoag APK file(org.acc.BridgeAnticoag_42_16054055.apk) from SameAPK.com to your PC (ex: /Users/xxx/Downloads/(org.acc.BridgeAnticoag_42_16054055.apk)), then follow these steps:

Using Emulator:

  • Download And Install one Emulator Softwares (Ex: Bluestacks, GenyMotion, NoxPlayer)
  • Simple install APK on PC by drag and drop file org.acc.BridgeAnticoag_42_16054055.apk on Emulator screen

ManageAnticoag APK Pros & Cons [menu]


Pros
  • This app is safe, it's not require high risk permissions
  • Compatible with 32 bit device (most Emulator using 32bit arch CPU)
  • Compatible with 64-bit device (some android device and current Bluestacks)

Cons
Everything is good.


Similar applications [menu]


New Apps



Comments

No comment Yet.